- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Medical Devices (Northern Ireland Protocol) Regulations 2021.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
PART 2 Making available on the market and putting into service under Regulation (EU) 2017/745
Part 2A Making available on the market and putting into service under Regulation (EU) 2017/746
PART 3 Clinical investigations under Regulation (EU) 2017/745
A11.Legal representatives and contact persons for clinical investigations
12.Prior authorisation of clinical investigations by the Secretary of State
13.Arbitration following the refusal of a clinical investigation application
14.Damage compensation in relation to clinical investigations
15.Retention of documentation relating to clinical investigations
17.Clinical investigations not carried out for a purpose specified in Article 62(1)
PART 4 Notified bodies designated under Regulation (EU) 2017/745 and Regulation (EU) 2017/746
19B.Circumstances in which a fee is payable in relation to a consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device
19C.Fees payable in connection with a consultation or further consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device
PART 5 General provision about language requirements and fees
PART 8 Amendment of the Medical Devices Regulations 2002
31.Amendment of regulation 2A (medical devices which are qualifying Northern Ireland goods)
33.Amendment of regulation 10A (UK(NI) indication: general medical devices)
34.Amendment of regulation 19 (registration of persons placing general medical devices on the market)
35.Amendment of regulation 21B (registration of persons placing active implantable medical devices on the market)
36.Amendment of regulation 24A (UK(NI) indication: active implantable medical devices)
37.Amendment of regulation 36A (UK(NI) indication: in vitro diagnostic medical devices)
PART 9 Amendments of other secondary legislation
38.Amendment of the Blood Safety and Quality Regulations 2005
39.Amendment of the Human Tissue (Quality and Safety for Human Application) Regulations 2007
40.Amendment of the Legislative and Regulatory Reform (Regulatory Functions) Order 2007
41.Amendment of the Medicines (Products for Human Use) (Fees) Regulations 2016
42.Amendment of the Economic Growth (Regulatory Functions) Order 2017
43.Amendment of the Market Surveillance (Northern Ireland) Regulations 2021
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: